A novel immune-related model to predict prognosis and responsiveness to checkpoint and angiogenesis blockade therapy in advanced renal cancer

BACKGROUND: Immune checkpoint blockade (ICB) and anti-angiogenic drug combination has prolonged the survival of patients with advanced renal cell carcinoma (RCC). However, not all patients receive clinical benefits from this intervention. In this study, we aimed to establish a promising immune-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peng, Bi, Feng, Tan, Weili, Jian, Lian, Yu, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043594/
https://www.ncbi.nlm.nih.gov/pubmed/36998443
http://dx.doi.org/10.3389/fonc.2023.1127448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043594/
https://www.ncbi.nlm.nih.gov/pubmed/36998443
http://dx.doi.org/10.3389/fonc.2023.1127448

Ejemplares similares